Transient expansion of vestibular schwannoma following stereotactic radiosurgery

被引:121
|
作者
Nagano, Osamu [1 ]
Higuchi, Yoshinori
Serizawa, Toru [3 ]
Ono, Junichi [2 ]
Matsuda, Shinji [4 ]
Yamakami, Iwao
Saeki, Naokatsu
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuou Ku, Chiba 2600856, Japan
[2] Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan
[3] Chiba Cardiovasc Ctr, Gamma Knife House, Ichihara, Chiba, Japan
[4] Chiba Cardiovasc Ctr, Dept Neurol, Ichihara, Chiba, Japan
关键词
facial nerve function; Gamma Knife surgery; stereotactic radiosurgery; transient tumor expansion; trigeminal nerve dysesthesia; vestibular schwannoma;
D O I
10.3171/JNS/2008/109/11/0811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The authors prospectively analyzed volume changes in vestibular schwannomas (VSs) after stereotactic radiosurgery. Methods. One hundred Consecutive patients with unilateral VS treated with Gamma Knife Surgery (GKS) at Chiba Cardiovascular Center between 1998 and 2006 were analyzed in this study. For each lesion the Gd-enhanced volume was measured serially every 3 months in the 1st year, then every 6 months thereafter, using volumetric software. The frequency and degree of transient tumor expansion were documented and possible prognostic factors were analyzed. Concurrently, neurological deterioration involving trigeminal, facial, and cochlear nerve functions were also assessed. Results. The mean observation period was 65 months (range 25-100 months). There were 32 men and 68 women whose mean age was 59.1 years (range 29-80 years). Tumor volumes at GKS averaged 2.7 cm(3) (range 0.1-13.2 C 113), and the lesions were irradiated at the mean 52.2% isodose line for the tumor margin (range 50-67%), with a mean dose of 12.2 Gy (range 10.5-13 Gy) at the periphery. The tumor Volume was increased by 23% at 3 months and 27% at 6 months. Tumors shrank to their initial size over a mean period of 12 months. The maximum volume increase was < 10% (no significant increase) in 26 patients, 10-30% in 23, 30-50% in 22, 50-100% in 16, and > 100% in 13. The peak tumor expansion averaged 47% (range 0-613%). A high-dose (>= 3.5 Gy/min) treatment appears to be the greatest risk factor for transient tumor expansion, although the difference did not reach statistical significance. Transient facial palsy and facial dysesthesia correlated strongly with tumor expansion, but only half of the hearing loss was coincident with this phenomenon. Conclusions. Transient expansion of VSs after GKS was found to be much more frequent than previously reported, strongly Suggesting a correlation with deterioration of facial and trigeminal nerve functions.
引用
收藏
页码:811 / 816
页数:6
相关论文
共 50 条
  • [41] BPPV IS A SIGNIFICANT CAUSE OF DIZZINESS IN VESTIBULAR SCHWANNOMA TREATED WITH STEREOTACTIC RADIOSURGERY
    Jethwa, J.
    Williams, L.
    Davenport, S.
    Adonis, A.
    NEURO-ONCOLOGY, 2024, 26 : V127 - V128
  • [42] Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: A systematic review
    Yang, Isaac
    Aranda, Derrick
    Han, Seunggu J.
    Chennupati, Sravana
    Sughrue, Michael E.
    Cheung, Steven W.
    Pitts, Lawrence H.
    Parsa, Andrew T.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (06) : 742 - 747
  • [43] Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma
    Paek, SH
    Chung, HT
    Jeong, SS
    Park, CK
    Kim, CY
    Kim, JE
    Kim, DG
    Jung, HW
    CANCER, 2005, 104 (03) : 580 - 590
  • [44] Koos grade IV vestibular schwannoma treated with stereotactic radiosurgery Response
    Pikis, Stylianos
    Mantziaris, Georgios
    Sheehan, Jason P.
    JOURNAL OF NEUROSURGERY, 2023, 139 (02)
  • [45] Stereotactic fractionated radiotherapy and LINAC-radiosurgery in the treatment of vestibular schwannoma
    Ladar, C
    Grosu, A
    Fauser, C
    Oestreicher, E
    Pinsker, K
    Jaeger, R
    Staerk, S
    Arnold, W
    Lumenta, C
    Molls, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S313 - S314
  • [47] Associations With Changes in Disease-Specific Quality of Life Following Stereotactic Radiosurgery for Sporadic Vestibular Schwannoma
    Babajanian, Eric E.
    Daher, Ghazal S.
    Dornhoffer, James R.
    Khandalavala, Karl R.
    Marinelli, John P.
    Lohse, Christine M.
    Link, Michael J.
    Carlson, Matthew L.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2025,
  • [48] Fractionated Stereotactic Radiotherapy Compared to Stereotactic Radiosurgery for Vestibular Schwannoma in Patients with Type 2 Neurofibromatosis
    Mauro, Geovanne Pedro
    Da Roz, Leila Maria
    Gico, Vinicius de Carvalho
    Weltman, Eduardo
    de Souza, Evandro Cesar
    Figueiredo, Eberval Gadelha
    Teixeira, Manoel Jacobsen
    WORLD NEUROSURGERY, 2023, 179 : E416 - E420
  • [49] Hearing Outcomes After Stereotactic Radiosurgery for Unilateral Intracanalicular Vestibular Schwannomas: Implication of Transient Volume Expansion
    Kim, Young-Hoon
    Kim, Dong Gyu
    Han, Jung Ho
    Chung, Hyun-Tai
    Kim, In Kyung
    Song, Sang Woo
    Park, Jeong-Hoon
    Kim, Jin Wook
    Kim, Yong Hwy
    Park, Chul-Kee
    Kim, Chae-Yong
    Paek, Sun Ha
    Jung, Hee-Won
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 61 - 67
  • [50] Delayed Vestibular Schwannoma Regrowth Following Shrinkage After Stereotactic Radiosurgery: Implication for Life-Long Surveillance
    Stapleton, Emma
    Crowther, John A.
    Locke, Richard
    Kontorinis, Georgios
    OTOLOGY & NEUROTOLOGY, 2017, 38 (02) : 260 - 263